MARATTO

article · Suez Canal University Medical Journal

Haematological Parameters and Inflammatory Markers in Systemic Lupus Erythematosus versus Rheumatoid Patients and their Relationship with Disease Activity

2024Open accessSuez Canal University

Abstract

Background: Changes in the quantity, forms, & dimensions of bone marrow cells & peripheral blood cells are brought about by the inflammatory process in rheumatic inflammatory illnesses, which is mediated by inflammatory cells & chemicals. Disagreement exists, nonetheless, about how inflammatory illnesses affect hematological parameters and inflammatory markers. Aim: To assess relations between hematological parameters and inflammatory markers & disease severity in RA and SLE patients. Subjects & Methods: A cross-sectional study was conducted on 60 patients divided into two groups: RA and SLE groups. Disease activity was assessed by Systemic lupus erythematosus disease activity score. All the patients were subjected to laboratory investigations. Results: The frequency of high disease activity was elevated among SLE patients (76.7%), and RA patients (60.0%). Disease activity scores showed significant direct correlations with age, disease duration, ESR and CRP among SLE patients and RA patients, while WBCs and PLT showed significant indirect correlations with disease activity in SLE group. Conclusions: Both the RA and SLE groups had noticeably increased ESR and CRP levels. For SLE, there are helpful diagnostic instruments, and RA indicates disease activity. Still, more study has to be done to standardize these instruments.

Research topics

  • Systemic Lupus Erythematosus Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/scumj.2024.428775

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.